T2 Biosystems EBIT

T2 Biosystems (TTOO) currently reports a EBIT of $-42M as of September 2024. That compares with $-50M in the prior-year period — up 16.7% year over year. That is below the Industrials sector average of $40B. Use the charts on this page to explore T2 Biosystems's EBIT history and peer comparisons.

T2 Biosystems's EBIT increased from $-50M to $-42M — a 16.7% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

T2 Biosystems's EBIT of $-42M is lower than the Industrials sector average of $40B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

T2 Biosystems reported $-42M in EBIT as of September 2024. That compares with $-50M in the prior-year period — up 16.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-42M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is $40B. From there, open related valuation or income-statement pages for T2 Biosystems, and consider following TTOO for alerts when major investors trade the stock.